Chlorpheniramine Safety in Infants Under 1 Year

Age-Specific Safety Thresholds

The American Academy of Pediatrics and other guidelines recommend that chlorpheniramine should NOT be used in infants under 6 months of age, and extreme caution is required for infants aged 6 months to 1 year, with dosing limited to 250 µg/kg only in emergency anaphylactic situations 1
Chlorpheniramine is contraindicated in routine use for infants under 6 months, according to the British guidelines 2
For anaphylaxis treatment only, the recommended dose is chlorphenamine 2.5 mg IM or IV slowly, as per the Anaesthesia guidelines 1
No evidence supports routine use for allergic rhinitis, urticaria, or atopic dermatitis in infants 6-12 months, as stated by the Journal of Microbiology, Immunology and Infection 3

Between 1969-2006, first-generation antihistamines, including chlorpheniramine, caused 69 fatalities in children ≤6 years, with 41 deaths occurring in children under 2 years, according to the Praxis Medical Insights guidelines 4
Special caution is required in patients with epilepsy, as convulsions have been reported with chlorpheniramine, as noted by the Journal of Microbiology, Immunology and Infection 3

Cetirizine is the preferred antihistamine for infants ≥6 months, with a well-tolerated safety profile similar to placebo, as recommended by the Praxis Medical Insights guidelines 2
Cetirizine has established efficacy and excellent safety in children over 6 months, with the shortest time to maximum concentration for rapid symptom relief, according to the Praxis Medical Insights guidelines 2, 4
Cetirizine requires dose reduction by 50% in moderate renal impairment, and should be avoided entirely in severe renal impairment, as stated by the Praxis Medical Insights guidelines 2, 4

Allergen avoidance and supportive care should be the primary management strategy for allergic symptoms in infants under 6 months, as recommended by the Praxis Medical Insights guidelines 2

Do not combine chlorpheniramine with other sedating medications without considering additive CNS depression effects, as warned by the Praxis Medical Insights guidelines 2
Avoid using chlorpheniramine for atopic dermatitis management, as current evidence shows insufficient benefit for antihistamines in treating itch associated with atopic dermatitis, according to the Journal of Microbiology, Immunology and Infection 3
The FDA advisory committees recommended against OTC cough/cold medications, which often contain first-generation antihistamines, in children under 6 years, due to the safety profile documented above, as stated by the Praxis Medical Insights guidelines 4